The Verspeeten Family Cancer Centre at London Health Sciences Centre is the regional cancer centre for south-western Ontario; with Western University it led SABR-COMET, the Canadian trial of stereotactic radiotherapy for patients with a few metastases.
The Verspeeten Family Cancer Centre, formerly the London Regional Cancer Program, is the Ontario Health regional cancer centre for south-western Ontario, located at London Health Sciences Centre's Victoria Hospital. It provides radiation oncology, medical oncology, haematology and stem cell transplantation, surgical oncology and supportive care, and hosts a large clinical trials programme. Research with Western University and Lawson Research Institute includes radiotherapy trials (the centre led the Canadian trials of stereotactic radiotherapy for oligometastatic disease, SABR-COMET), imaging and translational oncology, and Western's Cancer Research Laboratory Program.
From OpenAlex, oncology works in the last five years (2022 to 2026, current year in progress); counted on 2026-09-15.
Matched to London Health Sciences Centre, including child institutions. 183 works · 1,067 citations · 68% open access · 13% clinical trials · 4% reviews.
Canadian surgeon who led ORATOR, the first randomised trial to compare robotic surgery with radiotherapy for early throat cancer, which found swallowing was slightly better after radiotherapy.
Led SABR-COMET, the trial that showed treating a few metastases with high-dose radiation can prolong survival.
Hospital executive who leads the cancer programme at London Health Sciences Centre, home of the Verspeeten Family Cancer Centre, and the South West Regional Cancer Program in Ontario.
Shares David A. Palma, SBRT / SABR (stereotactic radiotherapy).
Shares Ontario Health (Cancer Care Ontario), SBRT / SABR (stereotactic radiotherapy).
Shares David A. Palma, SBRT / SABR (stereotactic radiotherapy).